Spots Global Cancer Trial Database for Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
Official Title: Effects of Simvastatin on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Prospective, Randomized Trial.
Study ID: NCT00365638
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether statins (simvastatin) improve clinical (excessive hair, skin problems), endocrine (androgens) and metabolic (lipids, markers of systemic inflammation) in women with polycystic ovary syndrome (PCOS).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics, Poznan, , Poland
Contact Details
Name: Leszek Pawelczyk, MD PhD
Affiliation: Poznan University of Medical Sciences
Role: PRINCIPAL_INVESTIGATOR
Name: Antoni J Duleba, MD
Affiliation: Yale University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
